Ruochan Chen
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Inflammasome and immune disorders 4
- RNA modifications and cancer 4
- Immunology 12
- Immune Response and Inflammation 6
- Co-authors
- Daolin Tang (22 shared papers)Rui Kang (18 shared papers)Xiaofang Sun (3 shared papers)Xiaohua Niu (2 shared papers)De Chen (1 shared paper)Zhanhui Ou (1 shared paper)Herbert J. Zeh (7 shared papers)Xuegong Fan (8 shared papers)
- Journals
- Infectious Diseases and Therapy (4 papers)Hepatology (3 papers)Frontiers in Medicine (3 papers)Frontiers in Immunology (2 papers)Antioxidants and Redox Signaling (2 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Ruochan Chen
52 papers receiving 4.9k citations
Ruochan Chen's Hit Papers
Peers
Comparison fields: 5 of 114
- Clinical Biochemistry 680
- Cancer Research 1.3k
- Pulmonary and Respiratory Medicine 1.9k
- Immunology 716
- Molecular Biology 2.3k
Countries citing papers authored by Ruochan Chen
This map shows the geographic impact of Ruochan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruochan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruochan Chen more than expected).
Fields of papers citing papers by Ruochan Chen
This network shows the impact of papers produced by Ruochan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruochan Chen. The network helps show where Ruochan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruochan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells Hit paper breakdown → | 2015 | 1613 |
| 2 | HMGB1 in health and disease Hit paper breakdown → | 2014 | 797 |
| 3 | The mechanism of HMGB1 secretion and release Hit paper breakdown → | 2022 | 575 |
| 4 | Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis Hit paper breakdown → | 2016 | 562 |
| 5 | 2019 | 118 | |
| 6 | 2020 | 116 | |
| 7 | 2017 | 114 | |
| 8 | 2021 | 108 | |
| 9 | 2013 | 102 | |
| 10 | 2016 | 60 | |
| 11 | Pattern recognition receptors: function, regulation and therapeutic potential Hit paper breakdown → | 2025 | 59 |
| 12 | 2022 | 57 | |
| 13 | 2018 | 54 | |
| 14 | 2018 | 49 | |
| 15 | 2016 | 48 | |
| 16 | 2023 | 45 | |
| 17 | 2019 | 38 | |
| 18 | 2020 | 33 | |
| 19 | 2016 | 28 | |
| 20 | 2015 | 27 |
About Ruochan Chen
Ruochan Chen is a scholar working on Molecular Biology, Immunology, Epidemiology, Clinical Biochemistry and Cancer Research, having authored 54 papers that have together received 4.9k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (10 papers), Hepatitis B Virus Studies (7 papers), Ferroptosis and cancer prognosis (7 papers), Immune Response and Inflammation (6 papers), Cancer-related molecular mechanisms research (5 papers), Inflammasome and immune disorders (4 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Clinical Biochemistry (680 citations), Cancer Research (1.3k citations), Pulmonary and Respiratory Medicine (1.9k citations), Immunology (716 citations) and Molecular Biology (2.3k citations). Ruochan Chen has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Daolin Tang, Rui Kang, Xiaofang Sun, Xiaohua Niu, De Chen, Zhanhui Ou, Herbert J. Zeh, Xuegong Fan, Michael T. Lotze and Timothy R. Billiar. Their work appears in journals such as Infectious Diseases and Therapy, Hepatology, Frontiers in Medicine, Frontiers in Immunology and Antioxidants and Redox Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.